FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Leerink Partners raised its price target on Exact Sciences (NASDAQ: EXAS) to $67.00 (from $63.00) while maintaining an Outperform rating. Leerink Partners remains bullish on EXAS given their view that Cologuard remains highly underpenetrated in an 80M-patient strong market, per the company, where EXAS could... More

